Molbio Diagnostics LimitedNSE: MOLBIO

Press Release Sep 07 2026 09: 40: 56

· Issued by Molbio Diagnostics Limited via NSE India

Filed with NSE · · 4 pages · English

Summary by 6ix AI

The company reported total income significantly higher than the same quarter last year, driven by increased consumption of Truenat test kits. EBITDA and profit after tax also showed substantial improvement compared to the previous year, reflecting operational leverage and growth in revenue. Management emphasized the importance of assessing performance on a full-year basis due to the non-linear revenue profile of the business.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Molbio Diagnostics Limited on 6ix

In the deck